AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21109054
Drug: Sedative massage
RxNorm normalized name: MedActive Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedative massage
Trial: 1715503
Drug: Digital rectal
RxNorm normalized name: BD Thermometer Digital Rectal (obsolete)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital rectal screening and prostate-specific antigen (PSA) measurement
Trial: 22427481
Drug: IDX320 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDX320 50 mg once daily for 3 days
Trial: 22427481
Drug: IDX320 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDX320 100 mg once daily for 3 days
Trial: 22427481
Drug: IDX320 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDX320 200 mg once daily for 3 days
Trial: 22427481
Drug: IDX320 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDX320 400 mg once daily for 3 days
Trial: 22427481
Drug: IDX320 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDX320 200 mg twice daily for 3 days
Trial: 14656275
Drug: Newer drugs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Newer drugs added to carboplatin-paclitaxel (TC)
Trial: 14656275
Drug: Anti-idiotype CA
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-idiotype CA 125 antibodies
Trial: 14656275
Drug: Epidermal growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidermal growth factor receptor (EGFR) modulation
Trial: 10606017
Drug: Commercial ELISA
RxNorm normalized name: pseudopterogorgia elisabethae extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial ELISA for detecting serum antibody to Neospora caninum
Trial: 10606017
Drug: Immunofluorescent antibody
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunofluorescent antibody test (IFAT)
Trial: 1850971
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir (2 g/day in three doses for 10 days)
Trial: 7327785
Drug: Therapist directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapist directed training with self-help materials plus 10 individual treatment sessions
Trial: 27133225
Drug: DANCIN intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DANCIN intervention (30 minutes/twice-weekly sessions for 12 weeks)
Trial: 15708031
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of viable bacille Calmette-Guérin (BCG)
Trial: 15708031
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment with BCG
Trial: 10648270
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (1000 mg Ca/d as calcium carbonate, 5 d/wk for 12 months)
Trial: 3545718
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg bid)
Trial: 31766273
Drug: Egg yolk
RxNorm normalized name: EGG YOLK
DrugBank: Egg yolk (DB10530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Egg yolk phospholipid drink containing 3 g of phospholipid bound choline
Trial: 31766273
Drug: Control drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control drink with 3 g of choline bitartrate
Trial: 16937475
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy (20 mg omeprazole b.i.d., 1000 mg amoxicillin b.i.d., 500 mg clarithromycin b.i.d.)
Trial: 16937475
Drug: Standard quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard quadruple therapy (20 mg omeprazole b.i.d., 1000 mg amoxicillin b.i.d., 240 mg colloidal bismuth subcitrate b.i.d., and 500 mg metronidazole b.i.d.)
Trial: 16937475
Drug: Ampicillin-sulbactam-based quadruple
RxNorm normalized name: ampicillin / sulbactam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin-sulbactam-based quadruple therapy (375 mg sultamicillin b.i.d.)
Trial: 15319615
Drug: Interviewer-administered telephone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer-administered telephone surveys
Trial: 15319615
Drug: Self-administered mail
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered mail surveys with telephone reminder calls
Trial: 15319615
Drug: Self-administered mail
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered mail surveys
Trial: 15319615
Drug: Both modes
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both modes of survey administration
Trial: 11173173
Drug: Sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual buprenorphine tablets
Trial: 26268935
Drug: Leflunomide 50
RxNorm normalized name: Leflunomide
DrugBank: Leflunomide (DB01097)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Leflunomide 50 mg/week (LEF50)
Trial: 26268935
Drug: Leflunomide 10
RxNorm normalized name: leflunomide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leflunomide 10 mg/day (LEF10)
Trial: 16995975
Drug: ALSS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALSS treatment
Trial: 12893079
Drug: Lower radiation
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower radiation dose to contralateral parotid glands
Trial: 10860694
Drug: Connecta Clave(R)
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Connecta Clave(R) (CC(R))
Trial: 7720142
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (GH) 0.2 IU/kg/d
Trial: 29798127
Drug: Ketotifen 1
RxNorm normalized name: ketotifen 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen 1 mg 2 times/day oral treatment
Trial: 29798127
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treatment (antitussive, expectorant, and inhaled corticosteroids)
Trial: 21620644
Drug: 20% oral
RxNorm normalized name: K-Sol 20% Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% oral sucrose
Trial: 19033369
Drug: Elagolix (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elagolix (50-200 mg daily or 100 mg twice daily for 7 days)
Trial: 19033369
Drug: Elagolix (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elagolix (single oral dose of 25-400 mg)
Trial: 15385103
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin 50 mg/m² every 28 days
Trial: 15385103
Drug: Topotecan 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan 1.5 mg/m² per day for 5 days every 21 days
Trial: 15385103
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin 50 mg/m² every 28 days (for platinum-sensitive disease)
Trial: 15385103
Drug: Topotecan 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan 1.5 mg/m² per day for 5 days every 21 days (for platinum-sensitive disease)
Trial: 15385103
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin 50 mg/m² every 28 days (for all randomized subjects)
Trial: 15385103
Drug: Topotecan 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan 1.5 mg/m² per day for 5 days every 21 days (for all randomized subjects)
Trial: 11907946
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg E2/0.25 mg NETA
Trial: 11907946
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg E2/0.5 mg NETA
Trial: 7673613
Drug: omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 20 mg once daily for 8 weeks
Trial: 31409606
Drug: lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lansoprazole 30 mg once daily for 8 weeks
Trial: 7673613
Drug: lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lansoprazole 30 mg once daily for 6 weeks
Trial: 7673613
Drug: omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 20 mg once daily for 6 weeks
Trial: 7447829
Drug: Metrizamide 280
RxNorm normalized name: metrizamide
DrugBank: Metrizamide (DB01578)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metrizamide 280 mg/ml
Trial: 7447829
Drug: Metrizamide 180
RxNorm normalized name: metrizamide
DrugBank: Metrizamide (DB01578)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metrizamide 180 mg/ml
Trial: 28886907
Drug: qHPV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: qHPV vaccine (control)
Trial: 26355492
Drug: i-gel size
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: i-gel size 1.5
Trial: 26355492
Drug: i-gel size
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: i-gel size 2
Trial: 26355492
Drug: i-gel size
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: i-gel size 2.5
Trial: 26355492
Drug: i-gel size
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: i-gel size 3
Trial: 21420586
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac 0.1% applied 2 hours before PRK
Trial: 21420586
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac 0.1% applied every 6 hours for 2 days postoperatively
Trial: 7751567
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy with PCR detection after 3 days
Trial: 7751567
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy with PCR detection after 7 days
Trial: 2839019
Drug: enalapril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril (2.5 to 40 mg/day)
Trial: 18209133
Drug: Cochlear implant
RxNorm normalized name: Cochlearia officinalis leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochlear implant activated (on)
Trial: 18209133
Drug: Cochlear implant
RxNorm normalized name: Cochlearia officinalis leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochlear implant deactivated (off)
Trial: 16545724
Drug: Once-daily filgrastim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily filgrastim at 400 microg/m(2)/d
Trial: 16545724
Drug: Twice-daily filgrastim
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily filgrastim at 400 microg/m(2)/d
Trial: 8659426
Drug: CAST with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAST with 150 ml of contrast material
Trial: 8659426
Drug: CAST with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAST with 125 ml of contrast material
Trial: 8659426
Drug: CAST with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAST with 100 ml of contrast material
Trial: 8659426
Drug: Control with
RxNorm normalized name: Azo Bladder Control With Go Less
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control with 150 ml of contrast material
Trial: 8659426
Drug: Control with
RxNorm normalized name: Azo Bladder Control With Go Less
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control with 100 ml of contrast material
Trial: 3908884
Drug: Oestriol 3
RxNorm normalized name: Oestriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestriol 3 mg daily for 3 months
Trial: 20658006
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy (AsGaAl laser, 40mW power, 80J/cm² for 16 seconds at four selected points, one session)
Trial: 15071488
Drug: Delapril-Manidipine combination
RxNorm normalized name: manidipine
DrugBank: Manidipine (DB09238)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delapril-Manidipine combination
Trial: 15071488
Drug: Irbesartan-Hydrochlorothiazide combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan-Hydrochlorothiazide combination
Trial: 12479682
Drug: Drug trials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug trials in mania, specific interventions not detailed
Trial: 12479682
Drug: Various treatments,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatments, alone or in combination, specific interventions not detailed
Trial: 9619120
Drug: Curcumin 2
RxNorm normalized name: MICROCRYSTALLINE CELLULOSE 3 mg in 40 g / CURCUMIN 2 mg in 40 g CUTANEOUS CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin 2 g/kg + Piperine 20 mg/kg in rats
Trial: 9619120
Drug: Curcumin 2
RxNorm normalized name: MICROCRYSTALLINE CELLULOSE 3 mg in 40 g / CURCUMIN 2 mg in 40 g CUTANEOUS CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin 2 g + Piperine 20 mg in humans
Trial: 7862267
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate (1 mg/kg body weight)
Trial: 7862267
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate (2 mg/kg body weight)
Trial: 7862267
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate (3 mg/kg body weight)
Trial: 7862267
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate (4 mg/kg body weight)
Trial: 2919758
Drug: Midazolam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.3 mg kg‐1)
Trial: 2919758
Drug: Thiopental (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (4 mg kg‐1)
Trial: 28653428
Drug: Dextroamphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine (10 mg daily for 3 weeks)
Trial: 23715519
Drug: Dietary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary intervention (supplementation with 1,200 mg n‐3 LCPUFAs per day and instructions to reduce arachidonic acid (AA) intake)
Trial: 10714846
Drug: pethidine 17.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pethidine 17.5 mg
Trial: 10714846
Drug: pentazocine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pentazocine 7.5 mg
Trial: 9175960
Drug: bupivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine with fentanyl 1 microgram ml‐1
Trial: 9175960
Drug: bupivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine with fentanyl 2 micrograms ml‐1
Trial: 9175960
Drug: bupivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine with fentanyl 3 micrograms ml‐1
Trial: 9175960
Drug: bupivacaine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine with fentanyl 4 micrograms ml‐1
Trial: 1313120
Drug: Prostaglandin E1
RxNorm normalized name: Prostaglandin E1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin E1 (PGE1) infusion at a rate of 30 ng.kg‐1.min‐1 during cardiopulmonary bypass (CPB)
Trial: 1313120
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (Control group)
Trial: 3886308
Drug: Amitriptyline (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (25 mg 3-times daily)
Trial: 28419448
Drug: Match condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Match condition (tablet)
Trial: 14738640
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no further treatment after endometrial resection)
Trial: 9012304
Drug: Etomidate in
RxNorm normalized name: etomidate Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate in lipid emulsion (0.51 mg/kg)
Trial: 9012304
Drug: Propofol in
RxNorm normalized name: propofol Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol in long chain triglyceride emulsion (3.04 mg/kg)
Trial: 3884690
Drug: Fluocortin butyl
RxNorm normalized name: fluocortin butyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluocortin butyl (FCB) 2 mg per day
Trial: 3884690
Drug: Fluocortin butyl
RxNorm normalized name: fluocortin butyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluocortin butyl (FCB) 4 mg per day
Trial: 3884690
Drug: Fluocortin butyl
RxNorm normalized name: fluocortin butyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluocortin butyl (FCB) 8 mg per day
Trial: 31219949
Drug: Concentration-Controlled Dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentration-Controlled Dosing (CC) of EC-MPS
Trial: 31219949
Drug: Fixed-Dosing (FD)
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-Dosing (FD) of EC-MPS
Trial: 28724273
Drug: Inhaled Salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled Salbutamol (200 micrograms)
Trial: 19228175
Drug: Lorazepam 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 4.5 mg/day
Trial: 17973945
Drug: ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ezetimibe (10 mg/day)
Trial: 14985218
Drug: Zinc (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (10 mg as acetate, twice daily for 5 days)
Trial: 14985218
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A (10,000 microg retinol equivalents, twice daily for 4 days)
Trial: 23949208
Drug: Collagen hydrolysate
RxNorm normalized name: collagen, hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen hydrolysate (CH) 2.5 g
Trial: 23949208
Drug: Collagen hydrolysate
RxNorm normalized name: collagen, hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen hydrolysate (CH) 5.0 g
Trial: 20564162
Drug: Paclitaxel (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (100 mg/m2 iv every 2 weeks)
Trial: 20564162
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin (PLD) (20 mg/m2 iv every 3 weeks)
Trial: 16224085
Drug: Intravenous heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous heparin sodium
Trial: 10410403
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml of dextran 40
Trial: 10410403
Drug: 1000 ml
RxNorm normalized name: TPN Bag 1000 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 ml of lactated Ringer's solution
Trial: 1688835
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline crystalloid solution
Trial: 1688835
Drug: Hetastarch colloid
RxNorm normalized name: Hetastarch
DrugBank: Hydroxyethyl Starch (DB09106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hetastarch colloid solution
Trial: 7064850
Drug: Acebutolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (100 mg)
Trial: 22032759
Drug: Desvenlafaxine 25
RxNorm normalized name: DESVENLAFAXINE 25 mg ORAL TABLET, EXTENDED RELEASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 25 mg/d
Trial: 22032759
Drug: Desvenlafaxine 50
RxNorm normalized name: desvenlafaxine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 50 mg/d every other day
Trial: 22032759
Drug: Desvenlafaxine 50/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 50/25 mg/d
Trial: 22032759
Drug: Desvenlafaxine 50
RxNorm normalized name: desvenlafaxine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 50 mg/d - placebo
Trial: 22032759
Drug: No taper
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No taper
Trial: 17230059
Drug: Duration and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duration and type of chelation therapy
Trial: 17230059
Drug: Age of
RxNorm normalized name: TITANIUM DIOXIDE 20 mg in 1 g TOPICAL STICK [Flormar Delicious Lip Stylo Sunscreen Broad Spectrum SPF 15 DS10 Collage of Citrus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Age of beginning chelation therapy
Trial: 12153824
Drug: Methylphenidate (moderate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (moderate and high doses)
Trial: 10201459
Drug: Omeprazole 10
RxNorm normalized name: omeprazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 10 mg daily (maintenance)